Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

Tailored T-cells specially designed to combat a half dozen viruses are safe and may be effective in preventing and treating multiple viral infections, according to research led by Children's National Hospital faculty.

18 Nov 2019

Study uncovers new factor in the development of childhood lymphoma

A study recently published in the renowned journal Blood, led by Kaan Boztug, Scientific Director of the St. Anna Children's Cancer Research Institute, the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Adjunct Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Associate Professor at the Medical University of Vienna, together with scientists from Israel, Germany, Turkey, Colombia, Argentina and the USA, investigated four patients from independent families with malignancy, autoimmunity and immunodeficiency.

19 Sep 2019

Scientists reveal the structure of a key protein in Epstein-Barr virus infection

Scientists at the Institute for Research in Biomedicine and the Molecular Biology Institute of Barcelona have published a study in the journal Nature Communications revealing the structure of a key protein, known as a portal, in Epstein-Barr virus infection.

29 Aug 2019

Study sheds light on likely conserved functions of gammaherpesvirus microRNAs

The discovery of thousands of host mRNAs targeted by gammaherpesvirus microRNAs (miRNAs) could shed light on the biology of gammaherpesviruses and how these pathogens establish lifelong infections, according to a study published August 8 in the open-access journal PLOS Pathogens by Scott Tibbetts of the University of Florida, and colleagues.

From PLOS ONE 13 Aug 2019

Researchers identify encephalitis as rare toxicity of immunotherapy treatment

After a cancer patient receiving an immunotherapy developed encephalitis and died 18 months into treatment, researchers at Vanderbilt-Ingram Cancer Center investigated why the complication occurred, performing a molecular analysis of the disease's pathology and mining data to determine the incidence of similar occurrences.

22 Jul 2019

How genetic differences in Epstein-Barr virus strains alter the way it behaves

Researchers at the University of Sussex have identified how differences in the genetic sequence of the two main strains of the cancer-associated Epstein-Barr virus can alter the way the virus behaves when it infects white blood cells.

19 Jul 2019

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system.

From Revvity 11 Jul 2019

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

New research from Johns Hopkins Medicine and Sheppard Pratt Health System shows that people in the study with schizophrenia also have higher levels of antibodies against the Epstein-Barr virus (EBV), a herpes virus that causes infectious mononucleosis, so-called mono.

9 Jan 2019

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Innovation in immuno-oncology is exploding and new technologies that are set to benefit many patients with cancer are being showcased in the highly diverse array of topics to be discussed at the ESMO Immuno-Oncology Congress, to be held 13-16 December in Geneva, Switzerland.

11 Dec 2018

Researchers discover possible path forward in preventing cancers tied to two viruses

Researchers from the University of Minnesota, the Howard Hughes Medical Institute, and the University of Toronto have discovered a possible path forward in preventing the development of cancers tied to two viruses, including the virus that causes infectious mononucleosis--more commonly known as mono or the "kissing disease"--that infects millions of people around the globe each year.

12 Nov 2018

Small populations of normal T cells could modify disease severity in patients with XLP1

Human SH2D1A mutations resulting in X-linked lymphoproliferative syndrome type 1 are associated with a unique susceptibility to the Epstein-Barr virus, which may lead to fatal infectious mononucleosis.

9 Nov 2018

Tick-borne disease is multiple microbial in nature

A study recently published in Scientific Reports discovered that 65% of Lyme disease patients irrespective of their disease stage respond to several microbes.

1 Nov 2018

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target drivers of cancer and other immune-related disorders, today announced that the first patient has been treated in its Phase 1/2 clinical trial of FLX475 in patients with various advanced cancers. FLX475 is an oral, small molecule CCR4 antagonist that selectively inhibits migration of regulatory T cells into the tumor microenvironment.

27 Sep 2018

Study provides complete picture of HPV virus-head and neck cancer connections

Human papillomavirus is widely known to cause nearly all cases of cervical cancer. However, you might not know that HPV also causes 70 percent of oropharyngeal cancer, a subset of head and neck cancers that affect the mouth, tongue, and tonsils.

12 Sep 2018

Study could open new therapeutic avenues to attack herpesviruses

Human cytomegalovirus is a leading cause of birth defects and transplant failures. As it's evolved over time, this virus from the herpes family has found a way to bypass the body's defense mechanisms that usually guards against viral infections. Until now, scientists couldn't understand how it manages to do so.

28 Aug 2018

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Tokyo Medical and Dental University study shows that ruxolitinib-induced inhibition of STAT3 activity blocks survival and reduces pro-inflammatory cytokine production in Epstein-Barr virus (EBV)-infected clonally proliferating T- or NK-cells in Chronic active Epstein-Barr virus infection.

20 Aug 2018

New study finds key factors behind differences in immune responses

Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds a study of 1,000 individuals carried out by EPFL and the Pasteur Institute.

6 Aug 2018

Discovery of genes could lead to development of novel therapies for EBV-related cancers

VCU Massey Cancer Center researchers have identified two genes that are responsible for governing the replication of the Epstein-Barr virus, an infection that drives the growth of several types of cancer.

21 Mar 2018

UCLA researchers describe herpes virus structure associated with Kaposi's sarcoma

UCLA researchers have provided the first description of the structure of the herpes virus associated with Kaposi's sarcoma, a type of cancer.

19 Jan 2018

High fat diet linked to increased risk of relapse in kids with MS

On the other hand, high vegetable intake may halve the risk of relapse, the findings indicate. Several genetic and environmental factors, including previous infection with Epstein Barr virus, exposure to cigarette smoke, and low vitamin D levels have all been associated with a heightened risk of MS.

9 Oct 2017

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

Study uncovers new factor in the development of childhood lymphoma

Scientists reveal the structure of a key protein in Epstein-Barr virus infection

Study sheds light on likely conserved functions of gammaherpesvirus microRNAs

Researchers identify encephalitis as rare toxicity of immunotherapy treatment

How genetic differences in Epstein-Barr virus strains alter the way it behaves

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

Schizophrenia patients have higher levels of antibodies against Epstein-Barr virus, study shows

ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients

Researchers discover possible path forward in preventing cancers tied to two viruses

Small populations of normal T cells could modify disease severity in patients with XLP1

Tick-borne disease is multiple microbial in nature

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

Study provides complete picture of HPV virus-head and neck cancer connections

Study could open new therapeutic avenues to attack herpesviruses

Researchers find STAT3 as therapeutic target for chronic active EBV infection

New study finds key factors behind differences in immune responses

Discovery of genes could lead to development of novel therapies for EBV-related cancers

UCLA researchers describe herpes virus structure associated with Kaposi's sarcoma

High fat diet linked to increased risk of relapse in kids with MS

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Epstein Barr Virus News and Research

Latest Epstein Barr Virus News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in